Chandigarh UT Health Dept Marks Inquiry Into Sale Of Branded Drugs At Jan Aushadhi Store

Chandigarh : The UT health department on Friday marked an inquiry to check on the sale of branded medicines at the Jan Aushadhi store at the Government Multi-Specialty Hospital (GMSH), Sector 16, premises.

The development came after a patient, who visited the hospital’s orthopaedics department after getting severe knee pain, filed a written complaint with the UT health director, stating that the Jan Aushadhi store gave her branded medicines in place of the generic ones and also issued a wrong bill.

“The Jan Aushadhi store sold branded medicine to me at a cost of ₹235, but gave me a bill for a purchase amounting to ₹201. The authorities must check on the sale of the store,” the patient said in her complaint.

Addressing the same, UT health secretary Yashpal Garg said, “After receiving the complaint, the drug inspector has been asked to check on the working of the Jan Aushadhi store and to submit a report.”

After the inquiry was marked, the drug inspector conducted a surprise check on the store.

The health department, in a statement said, it was observed during the inspection that the kendra had stocked both Jan Aushadhi drugs and other branded medicines for sale.

“Eight types of branded drugs were seized. Certified copies of certain purchase and sale bills for branded and generic drugs were also taken on record, as evidence of sale of both types of drugs,” it further read.

The statement stated that the matter will be investigated further and that it would consult the Pharmaceuticals and Medical Devices Bureau of India regarding the guidelines related to the sale of drugs.

“If the violations are confirmed, appropriate actions will be taken against the Jan Aushadhi Kendra,” it added.

  • Related Posts

    AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

    AstraZeneca Pharma India Limited has set up its new corporate office in Mumbai, marking an extension of company’s presence in India, reinforcing its ambition to transforming care by unlocking the…

    Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

    Exports of drugs and pharmaceuticals from the country have reported a growth of around 4.9% during the first six months of the current fiscal year, at $16.13 billion, as compared…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

    AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

    Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

    Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

    NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

    NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

    Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications

    Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications

    Cancer patient dies before ‘using’ Ayurvedic treatment, hospital to pay parents Rs 63,000

    Cancer patient dies before ‘using’ Ayurvedic treatment, hospital to pay parents Rs 63,000

    Fake beauty products with ₹6.9L face value seized from two shops; owners arrested

    Fake beauty products with ₹6.9L face value seized from two shops; owners arrested